Drug intelligence / Profile preview

Jinlian Xiaofeng Granules

Development stage: Unknown
Lead developer: Beijing Yingkerei Pharmaceutical Technology
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Jinlian Xiaofeng Granules is a botanical Traditional Chinese Medicine (TCM) drug candidate developed by Yingkerui (Tianjin) Innovative Pharmaceutical Research. Formulated as granules for oral administration, it is designed to treat chronic spontaneous urticaria (CSU), specifically targeting the "wind-heat" pattern according to TCM diagnostic criteria. The drug is currently being evaluated in Phase II clinical trials in China to assess its efficacy and safety in reducing wheal formation and pruritus. As a TCM formula, its mechanism likely involves multi-target anti-inflammatory and anti-allergic actions derived from its constituent herbal extracts.

Other names: 金莲消风颗粒

Beyond the preview

Go deeper on Jinlian Xiaofeng Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinlian Xiaofeng Granules.

Explore the full profile